Pantilgone, Baby Boy -.
HRN: 26-69-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2025
AMPICILLIN 250MG (VIAL)
02/20/2025
02/27/2025
IV
170mg
Q12H
PROM X 48 Hours
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes